{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:15:25Z","timestamp":1791288925262,"version":"4.3.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2013,3,7]],"date-time":"2013-03-07T00:00:00Z","timestamp":1362614400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0058696","type":"journal-article","created":{"date-parts":[[2013,3,7]],"date-time":"2013-03-07T21:58:30Z","timestamp":1362693510000},"page":"e58696","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Prevention of Arthritis by Locally Synthesized Recombinant Antibody Neutralizing Complement Component C5"],"prefix":"10.1371","volume":"8","author":[{"given":"Paolo","family":"Durigutto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Macor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Ziller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"De Maso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Fischetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Marzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Sblattero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Tedesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,3,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nrrheum.2009.180","article-title":"Rejuvenating the immune system in rheumatoid arthritis","volume":"5","author":"CM Weyand","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nrrheum.2009.181","article-title":"Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis","volume":"5","author":"PC Taylor","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.autrev.2009.03.010","article-title":"Prospective new biological therapies for rheumatoid arthritis","volume":"9","author":"L Senolt","year":"2009","journal-title":"Autoimmun Rev"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1136\/ard.2009.114652","article-title":"Estimation of a numerical value for joint damage-related physical disability in rheumatoid arthritis clinical trials","volume":"69","author":"JS Smolen","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrrheum.2009.182","article-title":"Treatment of rheumatoid arthritis: state of the art 2009","volume":"5","author":"RF van Vollenhoven","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"ref6","first-page":"433","article-title":"Terminal complement complex in synovial tissue from patients affected by rheumatoid arthritis, osteoarthritis and acute joint trauma","volume":"10","author":"A Corvetta","year":"1992","journal-title":"Clin Exp Rheumatol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/eji.200424895","article-title":"Complement activation by both classical and alternative pathways is critical for the effector phase of arthritis","volume":"34","author":"MA Hietala","year":"2004","journal-title":"Eur J Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"R173","DOI":"10.1186\/ar3926","article-title":"Abrogated RANKL expression in properdin-deficient mice is associated with better outcome from collagen-antibody induced arthritis","volume":"14","author":"P Dimitrova","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.4049\/jimmunol.1102310","article-title":"Role of C3a receptors, C5a receptors, and complement protein C6 deficiency in collagen antibody-induced arthritis in mice","volume":"188","author":"NK Banda","year":"2012","journal-title":"J Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1074-7613(02)00275-3","article-title":"Arthritis critically dependent on innate immune system players","volume":"16","author":"H Ji","year":"2002","journal-title":"Immunity"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1096\/fj.08-125849","article-title":"Enhanced susceptibility to low-dose collagen-induced arthritis in CR1\/2-deficient female mice--possible role of estrogen on CR1 expression","volume":"23","author":"KE Nilsson","year":"2009","journal-title":"FASEB J"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.4049\/jimmunol.1001564","article-title":"Essential role of complement mannose-binding lectin-associated serine proteases-1\/3 in the murine collagen antibody-induced model of inflammatory arthritis","volume":"185","author":"NK Banda","year":"2010","journal-title":"J Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2249.2009.04070.x","article-title":"Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis","volume":"159","author":"DA Copland","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.4049\/jimmunol.164.8.4340","article-title":"A role for complement in antibody-mediated inflammation: C5-deficient DBA\/1 mice are resistant to collagen-induced arthritis","volume":"164","author":"Y Wang","year":"2000","journal-title":"J Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1148\/radiol.2351041768","article-title":"Prevalence and costs of chronic disease in a health care system structured for treatment of acute illness","volume":"235","author":"JH Thrall","year":"2005","journal-title":"Radiology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1002\/art.34430","article-title":"Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5","volume":"64","author":"P Macor","year":"2012","journal-title":"Arthritis Rheum"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jaci.2011.02.016","article-title":"Recombinant allergens: what does the future hold?","volume":"127","author":"R Valenta","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1002\/1521-4141(2002010)32:10<2773::AID-IMMU2773>3.0.CO;2-G","article-title":"The cleavage site of C5 from man and animals as a common target for neutralizing human monoclonal antibodies: in vitro and in vivo studies","volume":"32","author":"R Marzari","year":"2002","journal-title":"Eur J Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.molimm.2007.09.025","article-title":"Anti-idiotypic response in mice expressing human autoantibodies","volume":"45","author":"R Di Niro","year":"2008","journal-title":"Mol Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.nbt.2011.12.005","article-title":"Simple scale-up of recombinant antibody production using an UCOE containing vector","volume":"29","author":"S Boscolo","year":"2012","journal-title":"N Biotechnol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1099\/0022-1317-73-3-653","article-title":"Construction of solid matrix-antibody-antigen complexes containing simian immunodeficiency virus p27 using tag-specific monoclonal antibody and tag-linked antigen","volume":"73","author":"T Hanke","year":"1992","journal-title":"J Gen Virol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/art.22492","article-title":"Selective therapeutic control of C5a and the terminal complement complex by anti-C5 single-chain Fv in an experimental model of antigen-induced arthritis in rats","volume":"56","author":"F Fischetti","year":"2007","journal-title":"Arthritis Rheum"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2005-03-1319","article-title":"Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor","volume":"106","author":"F Fischetti","year":"2005","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"10556","DOI":"10.1158\/0008-5472.CAN-07-1811","article-title":"In vivo targeting of human neutralizing antibodies against CD55 and CD59 to lymphoma cells increases the antitumor activity of rituximab","volume":"67","author":"P Macor","year":"2007","journal-title":"Cancer Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/eji.200425920","article-title":"Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59","volume":"35","author":"F Ziller","year":"2005","journal-title":"Eur J Immunol"},{"key":"ref26","first-page":"1","article-title":"The complement system: an overview","volume":"150","author":"BP Morgan","year":"2000","journal-title":"Methods Mol Biol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/art.10183","article-title":"Local production of complement proteins in rheumatoid arthritis synovium","volume":"46","author":"E Neumann","year":"2002","journal-title":"Arthritis Rheum"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1006\/bbrc.1999.0590","article-title":"Evaluation of cationic liposome suitable for gene transfer into pregnant animals","volume":"258","author":"T Ochiya","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"E92","DOI":"10.1208\/aapsj0901009","article-title":"Nonviral gene delivery: what we know and what is next","volume":"9","author":"X Gao","year":"2007","journal-title":"AAPS J"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1365-3083.2008.02119.x","article-title":"Boosting anti-idiotype immune response with recombinant AAV enhances tumour protection induced by gene gun vaccination","volume":"68","author":"M Cesco-Gaspere","year":"2008","journal-title":"Scand J Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.virol.2008.04.016","article-title":"Genetic delivery of an anti-RSV antibody to protect against pulmonary infection with RSV","volume":"378","author":"D Skaricic","year":"2008","journal-title":"Virology"},{"key":"ref32","first-page":"376","article-title":"Antivector and antitransgene host responses in gene therapy","volume":"2","author":"NR Hackett","year":"2000","journal-title":"Curr Opin Mol Ther"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.addr.2005.01.013","article-title":"DNA vaccines for biodefence","volume":"57","author":"HS Garmory","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2249.1997.511e-ce1408.x","article-title":"Local therapy with soluble complement receptor 1 (sCR1) suppresses inflammation in rat mono-articular arthritis","volume":"110","author":"RM Goodfellow","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0161-5890(99)00113-3","article-title":"Complement activation and inhibition in experimental models of arthritis","volume":"36","author":"SM Linton","year":"1999","journal-title":"Mol Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/03009740600844530","article-title":"A randomized, controlled study of a single intra-articular injection of etanercept or glucocorticosteroids in patients with rheumatoid arthritis","volume":"35","author":"H Bliddal","year":"2006","journal-title":"Scand J Rheumatol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3899\/jrheum.100828","article-title":"Etanercept compared to intraarticular corticosteroid injection in rheumatoid arthritis: double-blind, randomized pilot study","volume":"38","author":"CH Roux","year":"2011","journal-title":"J Rheumatol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0058696","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T04:10:06Z","timestamp":1540008606000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0058696"}},"subtitle":[],"editor":[{"given":"Cordula M.","family":"Stover","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,7]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0058696","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,7]]}}}